Maravai LifeSciences Holdings, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2022 | $544.0M | — | — |
| Mar 2022 | $524.5M | $382.6M | $431.5M |
| Jun 2022 | $523.7M | $456.6M | $550.7M |
| Sep 2022 | $522.8M | $503.8M | $617.4M |
| Dec 2022 | $522.0M | $545.2M | $632.1M |
| Mar 2023 | $521.2M | $521.5M | $628.3M |
| Jun 2023 | $520.3M | $520.6M | $580.2M |
| Sep 2023 | $519.5M | $519.3M | $579.6M |
| Dec 2023 | $518.7M | $416.8M | $575.0M |
| Mar 2024 | $517.9M | $410.7M | $561.7M |
| Jun 2024 | $517.1M | $434.7M | $573.2M |
| Sep 2024 | $516.3M | $344.9M | $578.2M |
| Dec 2024 | $290.5M | $325.3M | $322.4M |
| Mar 2025 | $289.5M | $300.6M | $285.1M |
| Jun 2025 | $288.4M | $265.9M | $269.9M |
| Sep 2025 | $287.4M | $245.4M | $243.6M |
| Dec 2025 | $286.3M | $212.4M | $216.9M |
| Mar 2026 | $235.6M | $211.6M | $165.9M |
| Jun 2026 | $146.0M | $204.6M | $70.1M |